Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Haliborange is a well-known line of multivitamin and mineral dietary supplements primarily designed for children and families to support growth, development, and overall immune health. Originally launched in the 1930s by Allen & Hanburys as a palatable alternative to cod liver oil, the brand has a long history of providing essential vitamins, particularly Vitamin A, Vitamin C, and Vitamin D3 (cholecalciferol), often combined with calcium, iron, or omega-3 fatty acids (such as DHA and EPA). In Italy, the brand is owned and distributed by Eurospital, which offers various formulations including chewable tablets, drops, and syrups to address nutritional deficiencies and support bone health and immune function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Haliborange.